Georg NEUWIRTHER will present UNICOM on May 5th at 10.00 AM. GERMAN SOCIETY FOR REGULATORY AFFAIRS (DGRA) The German Society for Regulatory Affairs e.V. is a scientific specialist society in […]
Central thema: Administrable products : Based on relationship between manufactured and administrable dose form, - NoMA's solution to meet needs in clinical practice. REGISTER
Public webinar intended for business, developers and technical audiences working for industry and national competent authorities that are interested in learning more about the Product Management Service (PMS) development progress and […]
This webinar is targeted at all European NCAs, eHealth competence centers and Industry (EMR, MPDs, HCP and Patient facing Apps). It will present and discuss the approach porposed by IHE […]
UNICOM partner will orchestrate a cross border use case in the interoperability showcase. GNOMON will also make one cross border presentation in the tech leaders stage in the exhibition hall.
You may already REGISTER
Unicom developments around IDMP from a NCA (AGES) perspective by George Neuwirther IDMP Ontology by Heiner Oberkampf and Raphael Sergent EU-SRS by Annet Rozema
A report on progress and challenges from the Global IDMP Working Group (GIDWG), about substances. The presentation will give an overview of the GIDWG work on global alignment of substances, […]
In the context of the IHE-Europe Connectathon WEEK 2023 | Connectathon in Rennes France and in parrallel to the French eHealth week. Looking across the landscape of IDMP implementation, the […]
REGISTER NOW FOR THIS EVENT Advanced FHIR training: How to track changes on a medicinal product? UNICOM is happy to invite all of you to the 4th NCA FHIR training on […]
Agenda: Introduction to Fimea Medicinal product database demo Lessons learned Priority actions expected from EMA Speakers: Joonas Tuominen (Fimea) Anu Ollikainen (Fimea) Markus Mäkelä (Fimea) Juha Jokimäki (Solita Finland Oy)
Unicom will be presenting all the results of WP2 related to SUBSTANCES
The UNICOM Innovation Action has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 875299.
